Gilead Sciences Inc (GILD)
US$ 106.74-0.91%
Price Chart
Key Statistics
Market Cap
$ 133.35B
P/E Ratio
22.52
Revenue (TTM)
$ 28.74B
Volume
6.97M
52W High
$ 118.28
52W Low
$ 63.95
Dividend Yield
2.95%
Beta
0.31
Technicals
50-Day MA
106.1012
200-Day MA
98.0009
52 Week High
118.2841
52 Week Low
63.9476
About GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Employees
17600
Headquarters
Foster City, CA
CEO
Mr. Daniel P. O'Day
Latest News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
22.15
Percentile: 30.98
Environmental Risk Score
0.53
Percentile: 2
Social Risk Score
12.97
Percentile: 2
Governance Risk Score
7.65
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
GILD
Category Average
2Moderate Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg